We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
-29.17%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$186M
AUM Growth
+$106M
Cap. Flow
+$5.12M
Cap. Flow %
2.76%
Top 10 Hldgs %
78.1%
Holding
120
New
32
Increased
25
Reduced
31
Closed
26

Top Buys

Rank Stock Value
1
TEUM
Pareteum Corporation
TEUM
+$5.9M
2
HIND
Vyome Holdings
HIND
+$3.25M
3
CRMD icon
CorMedix
CRMD
+$2.09M
4
TRAW icon
Traws Pharma
TRAW
+$1.84M
5
XBIO icon
Xenetic Biosciences
XBIO
+$1.45M

Top Sells

Rank Stock Value
1
AMPE
Ampio Pharmaceuticals Inc.
AMPE
+$2.04M
2
SHIPW
Seanergy Maritime Holdings Corp Class A Warrants
SHIPW
+$1.54M
3
ODT
Odonate Therapeutics, Inc. Common Stock
ODT
+$1.35M
4
BCLI
BRAINSTORM CELL THERAPUTC
BCLI
+$622K
5
CANF
Can-Fite BioPharma American Depositary Shares
CANF
+$610K

Sector Composition

Rank Sector Weight
1 Healthcare 14.92%
2 Technology 1.81%
3 Industrials 0.77%
4 Consumer Discretionary 0.32%
5 Real Estate 0.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALT icon
76
Altimmune
ALT
$581M
$81K 0.04%
41,758
+7,553
+22% +$16.7K
CSCI
77
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$74K 0.04%
721
+593
+463% +$128K
PLUR icon
78
PUT
Pluri
PLUR
$18.1M
$67K 0.04%
+22
New +$809
HYPD
79
Hyperion DeFi Inc
HYPD
$36.7M
$66K 0.04%
224
-395
-64% -$113K
VISL
80
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
$61K 0.03%
+961
New +$122K
SNES icon
81
SenesTech
SNES
$7.11M
$49K 0.03%
+1
New +$61K
BLCM
82
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$44K 0.02%
+4,201
New +$54.9K
TMDI
83
DELISTED
Titan Medical Inc. Ordinary Shares
TMDI
$44K 0.02%
41,085
-71,220
-63% -$149K
CARM
84
PUT
DELISTED
Carisma Therapeutics
CARM
$43K 0.02%
18
-10
-36% -$234
ORMP icon
85
PUT
Oramed Pharmaceuticals
ORMP
$171M
$43K 0.02%
+135
New +$450
IMNN icon
86
CALL
Imunon
IMNN
$6.43M
$40K 0.02%
1
– –
IMNN icon
87
PUT
Imunon
IMNN
$6.43M
$28K 0.02%
+1
New +$342
ALT icon
88
PUT
Altimmune
ALT
$581M
$26K 0.01%
134
-99
-42% -$219
TTNP
89
DELISTED
Titan Pharmaceuticals
TTNP
$22K 0.01%
+139
New +$62.7K
ONTXW
90
DELISTED
Onconova Therapeutics, Inc. Warrants
ONTXW
$13K 0.01%
631,812
-10,500
-2% -$736
DMK
91
PUT
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$8K ﹤0.01%
+2
New +$144
TTNP
92
PUT
DELISTED
Titan Pharmaceuticals
TTNP
– –
-3
Closed -$1.35K
BNTCW
93
DELISTED
Benitec Biopharma Limited
BNTCW
$1K ﹤0.01%
51,449
-5,500
-10% -$168
BNBX
94
PUT
DELISTED
BNB PLUS CORP
BNBX
– –
0
– -$78K
BCLI
95
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
– –
-10,543
Closed -$622K
BIIB icon
96
CALL
Biogen
BIIB
$30.4B
– –
-410
Closed -$9.59M
CANF
97
Can-Fite BioPharma American Depositary Shares
CANF
$6.77M
– –
-1,059
Closed -$610K
CATX icon
98
Perspective Therapeutics
CATX
$327M
– –
-37,061
Closed -$152K
CODX
99
Co-Diagnostics
CODX
$5.2M
– –
-9,320
Closed -$225K
COGT icon
100
Cogent Biosciences
COGT
$6.95B
– –
-12,731
Closed -$133K
1 2 3
4
5

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
CTC
Corundum Trust Company Sioux Falls, South Dakota $43.8M AUM 20.07% 1-Year Est. Return

Sabby Management's Q3 2019 Portfolio in Review

As of Q3 2019, Sabby Management held 120 positions worth $186M, up 133% from $79.5M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Sabby Management's Q3 2019 filing shows 32 new, 25 increased, 31 reduced and 26 closed positions. Its largest new stake was Pareteum Corporation: 2,248,578 shares worth $2.9M. The largest sale was Ampio Pharmaceuticals Inc., an estimated $2.04M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 37% a quarter earlier, followed by Technology and Industrials.

  • Sabby Management's largest Q3 2019 buy was Pareteum Corporation: 2,248,578 shares worth $2.9M.
  • Sabby Management added most to Advaxis Inc in Q3 2019, an estimated $1.01M increase.
  • Sabby Management's biggest Q3 2019 reduction was Odonate Therapeutics, Inc. Common Stock, cutting an estimated $1.35M.
  • Sabby Management fully exited Ampio Pharmaceuticals Inc. in Q3 2019, selling an estimated $2.04M.
  • Sabby Management's ten largest holdings make up 78% of its $186M portfolio in Q3 2019.
  • Sabby Management opened 32 new positions and closed 26 in Q3 2019.
  • Sabby Management's portfolio value rose 133% quarter-over-quarter to $186M.

Based on Sabby Management's 13F filing for Q3 2019, filed 15 Nov 2019.